Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide.

Slides:

Advertisements

Similar presentations

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Advertisements

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer

Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Cavernoscopic Removal of a Fungus Ball for Pulmonary Complex Aspergilloma Motoyasu Sagawa, MD, Tsutomu Sakuma, MD, Tsugimasa Isobe, MD, Makoto Sugita,

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Long-Term Survival With Chest Wall Resection and Pulmonary Metastasectomy for Hepatocellular Carcinoma Shinya Ito, MD, PhD, Takashi Yoshimura, MD, PhD,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Long-Term Survival After Salvage Surgery for Colorectal Lung Metastases Pietro Fabio Presicci, MD, Giulia Veronesi, MD, Massimiliano D'Aiuto, MD, Lorenzo.

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Persistent Cough Following Pulmonary Resection: Observational and Empiric Study of Possible Causes Noriyoshi Sawabata, MD, Hajime Maeda, MD, Shin-ichi.

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy Eduard L Mutsaerts, MSc, Frans A Zoetmulder, MD, Sybren Meijer,

Use of Amiodarone After Major Lung Resection

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Kuthan Kavakli, MD, Deniz Dogan, MD, Sedat Gurkok

Long-term results after pulmonary resection of renal cell carcinoma metastases Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W Wichmann, MD, Rudolf.

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease Steven M Keller, MD, Mark G Vangel, PhD, Henry Wagner,

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Is surgery for multiple lung metastases reasonable

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Heterogeneity of Tumor Sizes in Multiple Pulmonary Metastases of Colorectal Cancer as a Prognostic Factor Tomohiro Maniwa, MD, Keita Mori, PhD, Yasuhisa.

Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Editorial Board, January 2010

Pulmonary Resection for Metastases from Colorectal Cancer

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Early Intrapulmonary Recurrence After Pulmonary Metastasectomy Related to Colorectal Cancer Mi Ri Hwang, MD, Ji Won Park, MD, Dae Yong Kim, MD, Hee Jin.

Synchronous Mediastinal Ganglioneuroma and Retroperitoneal Pheochromocytoma Shin-ichi Takeda, MD, Masato Minami, MD, Yoshifumi Inoue, MD, Hikaru Matsuda,

Is there a role for pneumonectomy in pulmonary metastases?1

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience Hua Li, MD, PhD, Deming Xu,

Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients Masayoshi Inoue, MD, PhD, Osamu.

Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Noriyoshi Sawabata, MD, Mitsunori.

Benign Metastasizing Leiomyomas to the Lungs: An Institutional Case Series and a Review of the Recent Literature Jordan Miller, DO, Melina Shoni, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Stage III thymoma: Relationship of local invasion to recurrence

Neal S Goldstein, MD The Annals of Thoracic Surgery

The Development of an International Registry

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006 Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.

Pulmonary Artery Dissection Complicating Lung Transplantation for Primary Pulmonary Hypertension Yasushi Sakamaki, MD, Masato Minami, MD, Mitsunori Ohta,

Surgery for pulmonary metastases from colorectal carcinoma

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide Matsumura, MD, Kan Ideguchi, MD, Tsutomu Yasumitsu, MD, Katsuhiro Nakagawa, MD, Kenjiro Fukuhara, MD, Hajime Maeda, MD, Shin-ichi Takeda, MD, Masato Minami, MD, Yuko Ohno, PhD, Hikaru Matsuda, MD The Annals of Thoracic Surgery Volume 78, Issue 1, Pages 238-244 (July 2004) DOI: 10.1016/j.athoracsur.2004.02.017

Fig 1 Overall survival of 128 patients who underwent curative resection for pulmonary metastases from colorectal carcinoma. The 5-year survival rate was 45.3%. Median survival time was 49.5 months. The Annals of Thoracic Surgery 2004 78, 238-244DOI: (10.1016/j.athoracsur.2004.02.017)

Fig 2 Probability of survival according to the number and location (unilateral or bilateral) of metastatic lesions. The 5-year survival rate for patients with solitary, multiple unilateral, and multiple bilateral metastases was 50.6%, 40.3%, and 12.5%, respectively. The survival rate for patients with multiple bilateral metastases was worse than with a solitary lesion (p = 0.0028) and with multiple unilateral lesions (p = 0.0727). The Annals of Thoracic Surgery 2004 78, 238-244DOI: (10.1016/j.athoracsur.2004.02.017)

Fig 3 Probability of survival by Dukes' stage. The 5-year survival rate for patients with Dukes' A was 68.7% compared with 32.8% for patients with Dukes' B–D (significant, p = 0.0045). The Annals of Thoracic Surgery 2004 78, 238-244DOI: (10.1016/j.athoracsur.2004.02.017)

Fig 4 Probability of survival for patients who underwent a repeat pulmonary metastasectomy. The 3- and 5-year survival rates were 44.6% and 22.3%, respectively. Median survival time was 35.4 months. The Annals of Thoracic Surgery 2004 78, 238-244DOI: (10.1016/j.athoracsur.2004.02.017)